Skip to content
University of Oxford
True Planet (2021)
Oxford & Environmental Sustainability
Coronavirus Research (2020)
The Oxford Vaccine
Donate
You are here:
Our Research
Showing results for
Coronavirus
10th Feb 2021
Drug trial that could improve respiratory recovery from COVID-19 now underway
Coronavirus
Drug Development
10th Feb 2021
World Health Organization experts provide guidance on use of the Oxford vaccine
Coronavirus
Vaccine Development
9th Feb 2021
Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests
Coronavirus
Public Health
9th Feb 2021
NHS COVID-19 contact tracing app averted between 200,000 and 900,000 infections, estimates infectious disease experts
Coronavirus
Diagnostic Tools
Behaviour and Societal Impact
7th Feb 2021
ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults
Coronavirus
Vaccine Development
5th Feb 2021
Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK
Coronavirus
Vaccine Development
4th Feb 2021
Oxford leads first trial investigating dosing with alternating vaccines
Coronavirus
Vaccine Development
2nd Feb 2021
Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
Coronavirus
Vaccine Development
29th Jan 2021
European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine
Coronavirus
Vaccine Development
27th Jan 2021
63,000 extra deaths and a year off life expectancy: COVID in 2020 in England & Wales
Coronavirus
Epidemiology
Pagination
Go to
Previous
page
Go to page
12
Go to page
13
Go to page
14
Go to page
15
Go to page
16
Go to
Next
page